Nowmed Sweden AB was formed just over a year ago and quickly became part of an unlikely success story.

Together with the medical technology company Aegirbio in Lund, they presented an extensive sale of covid tests to Asia for a total of SEK 900 million.

The news attracted tens of thousands of stock savers to buy into Aegirbio, whose share price rose by hundreds of percent.

But in the autumn, it turned around for both the course and the news reporting.

SVT's review showed that there were several connections between Aegirbio's partner companies and players in the so - called mobile scam - a giant scam with VAT fraud where the state is suspected of having lost billions.

Two of the connections concerned Nowmed, and after its own investigation, Aegirbio announced that it had broken off cooperation with Gävleföretaget and taken over all orders with the Asian counterpart.

But the bad news was not over.

It turned out that the agreements could not be transferred, which according to Aegirbio was due to Nowmed not being able to bring about a written transfer.

Denies the connections

Aegirbio has repeatedly had to tone down the messages about the promised giant deals, and demands have been made that the company's information provision should be reviewed by the authorities.

Nowmed has now been declared bankrupt at its own request.

The company is insolvent with debts of more than SEK 31 million to Aegirbio.

Nowmed's CEO writes to SVT that the background to the bankruptcy is "publications made about alleged links to a VAT scam that we have nothing to do with, but which have made continued operations in the company very sadly impossible to conduct."

Aegirbio's chairman of the board, Anders Ingvarsson, writes that the bankruptcy does not involve any change in the situation regarding the orders.

According to him, negotiations are still ongoing between Aegirbio and the Thai distributor.

(Full comment below.)

On Friday night, Aegirbio released a press release stating that after a long process, it had received approval for its covid test for self-testing within the EU, a news that led to the share price soaring on Monday morning.

Read more: The stock market rocket's message of joy may have violated the law

Read more: The cannabis lobbyist behind Aegirbio's multimillion-dollar deal

Do you know more?

Contact SVT's reviewing reporters.